These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11064427)

  • 1. Aerosol therapy in cystic fibrosis: a survey of 54 CF centers.
    Borsje P; de Jongste JC; Mouton JW; Tiddens HA
    Pediatr Pulmonol; 2000 Nov; 30(5):368-76. PubMed ID: 11064427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
    Conway SP; Watson A
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
    [No Abstract]   [Full Text] [Related]  

  • 3. Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
    Davies LA; Nunez-Alonso GA; McLachlan G; Hyde SC; Gill DR
    Hum Gene Ther Clin Dev; 2014 Jun; 25(2):97-107. PubMed ID: 24865497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus.
    Heijerman H; Westerman E; Conway S; Touw D; Döring G;
    J Cyst Fibros; 2009 Sep; 8(5):295-315. PubMed ID: 19559658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol therapy during mechanical ventilation: an international survey.
    Ehrmann S; Roche-Campo F; Sferrazza Papa GF; Isabey D; Brochard L; Apiou-Sbirlea G;
    Intensive Care Med; 2013 Jun; 39(6):1048-56. PubMed ID: 23525741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosol treatment of cystic fibrosis.
    Garcia-Contreras L; Hickey AJ
    Crit Rev Ther Drug Carrier Syst; 2003; 20(5):317-56. PubMed ID: 14959788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: a preliminary report.
    König P; Gayer D; Barbero GJ; Shaffer J
    Pediatr Pulmonol; 1995 Oct; 20(4):205-14. PubMed ID: 8606849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.
    Laube BL; Geller DE; Lin TC; Dalby RN; Diener-West M; Zeitlin PL
    Respir Care; 2005 Nov; 50(11):1438-44. PubMed ID: 16253150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized therapy. SEPAR year.
    Olveira C; Muñoz A; Domenech A
    Arch Bronconeumol; 2014 Dec; 50(12):535-45. PubMed ID: 24997131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aerosol therapy and cystic fibrosis: a national survey].
    Huet F; Nivelon JL
    Rev Pneumol Clin; 1997; 53(2):91-7. PubMed ID: 9205688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.
    Bakker EM; Volpi S; Salonini E; Müllinger B; Kroneberg P; Bakker M; Hop WC; Assael BM; Tiddens HA
    Pediatr Pulmonol; 2014 Feb; 49(2):154-61. PubMed ID: 23913868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study.
    Fauroux B; Itti E; Pigeot J; Isabey D; Meignan M; Ferry G; Lofaso F; Willemot JM; Clément A; Harf A
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2265-71. PubMed ID: 11112150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy.
    Garcia-Contreras L; Hickey AJ
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1491-504. PubMed ID: 12458157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vibrating-mesh nebulizer maintenance by CF patients: Results from a French survey.
    Baravalle-Einaudi M; Dufeu N; Dupont C; Vecellio L; Delaisi B; Carsin A; Dubus JC;
    Pulm Pharmacol Ther; 2017 Jun; 44():57-60. PubMed ID: 28315491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA; Hilton J; Jepson B; Smith L
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group.
    Geller DE; Eigen H; Fiel SB; Clark A; Lamarre AP; Johnson CA; Konstan MW
    Pediatr Pulmonol; 1998 Feb; 25(2):83-7. PubMed ID: 9516090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
    Spencer DA
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
    [No Abstract]   [Full Text] [Related]  

  • 18. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE; Godovchik JE; Donn KH; Busick DR; Goralski J; Locke LW; Markovetz MR; Myerburg MM; Muthukrishnan A; Weber L; Lacy RT; Pilewski JM
    Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis.
    O'Connell OJ; O'Farrell C; Harrison MJ; Eustace JA; Henry MT; Plant BJ
    Respir Care; 2011 Jun; 56(6):771-5. PubMed ID: 21333079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aerosol delivery devices for cystic fibrosis.
    Kesser KC; Geller DE
    Respir Care; 2009 Jun; 54(6):754-67; discussion 767-8. PubMed ID: 19467162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.